Health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes

Health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes

Abstract Background Glucagon-like peptide-1 (GLP-1) receptor agonists are often recommended as part of combination therapy for type 2 diabetes when oral medication does not result in sufficient glycemic control. Several GLP-1 receptor agonists are available as weekly injections. These medications va...

Full description

Bibliographic Details
Main Authors: Louis S. Matza, Kristina S. Boye, Katie D. Stewart, Evan W. Davies, Rosirene Paczkowski
Format: Article
Language:English
Published: BMC 2017-11-01
Series:BMC Health Services Research
Subjects:
Utility, type 2 diabetes
Injection process
GLP-1 receptor agonist
Time trade-off
Weekly injection
Online Access:http://link.springer.com/article/10.1186/s12913-017-2648-7

Internet

http://link.springer.com/article/10.1186/s12913-017-2648-7

Similar Items